MedTrace Logo

Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients

NCT02853097 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2021-04-05

No results posted yet for this study

Summary

This research trial studies cell-free deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in blood from patients with prostate cancer that does not respond to hormone therapy and has spread to other places in the body. Studying samples of blood from patients with prostate cancer may help doctors to learn more about the changes that occur in tumor cells over time and how they become resistant to anti-cancer drugs.

Conditions

  • Hormone-Resistant Prostate Cancer
  • Metastatic Prostate Carcinoma
  • Prostate Adenocarcinoma

Interventions

OTHER

Cytology Specimen Collection Procedure

Undergo blood collection

OTHER

Laboratory Biomarker Analysis

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Southern California

    lead OTHER

Principal Investigators

  • Jacek Pinski, MD · University of Southern California

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-14
Primary Completion
2020-09-27
Completion
2020-09-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02853097 on ClinicalTrials.gov